Predictions
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€19.30
14.06.21
14.06.21
€22.00
14.06.22
14.06.22
6.74%
17.06.21
17.06.21
Could be worthwhile Investment >10% per year
CareCloud Inc.
Start price
Target price
Perf. (%)
€7.30
12.06.21
12.06.21
€8.50
12.06.22
12.06.22
-6.16%
10.07.21
10.07.21
Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€18.77
11.06.21
11.06.21
€23.20
11.06.22
11.06.22
-14.32%
24.06.21
24.06.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
M1 Kliniken AG
Start price
Target price
Perf. (%)
€10.35
31.05.21
31.05.21
-
31.05.24
31.05.24
40.10%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Haemato AG
Start price
Target price
Perf. (%)
€29.20
31.05.21
31.05.21
-
31.05.24
31.05.24
-36.99%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.74
31.05.21
31.05.21
€15.00
31.05.22
31.05.22
-60.61%
01.06.22
01.06.22
Fair valuation
Strong uniques
Leading role in innovation
Bad rating
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.18
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
4.59%
14.06.21
14.06.21
Could be worthwhile Investment >10% per year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€2.44
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
-2.46%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Aravive, Inc.
Start price
Target price
Perf. (%)
€4.16
31.05.21
31.05.21
€7.00
31.05.22
31.05.22
1.44%
14.06.21
14.06.21
Could be worthwhile Investment >10% per year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€7.24
31.05.21
31.05.21
€12.00
31.05.22
31.05.22
0.62%
14.06.21
14.06.21
Could be very worthwhile Investment >20% year
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€2.86
29.05.21
29.05.21
-
29.05.22
29.05.22
-71.59%
30.05.22
30.05.22
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€125.18
28.05.21
28.05.21
€200.00
28.05.22
28.05.22
-35.69%
29.01.22
29.01.22
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€9.52
27.05.21
27.05.21
€32.00
27.05.22
27.05.22
-55.61%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€75.60
26.05.21
26.05.21
€82.00
26.05.22
26.05.22
-36.11%
27.05.22
27.05.22
Aravive, Inc.
Start price
Target price
Perf. (%)
€3.92
17.05.21
17.05.21
€5.00
17.05.22
17.05.22
6.12%
31.05.21
31.05.21
Could be worthwhile Investment >10% per year
Flexion Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.65
17.05.21
17.05.21
€8.00
17.05.22
17.05.22
1.50%
31.05.21
31.05.21
Could be worthwhile Investment >10% per year
Kezar Life Sciences
Start price
Target price
Perf. (%)
€4.44
17.05.21
17.05.21
€6.00
17.05.22
17.05.22
2.70%
31.05.21
31.05.21
Could be worthwhile Investment >10% per year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€6.73
17.05.21
17.05.21
€8.00
17.05.22
17.05.22
7.58%
31.05.21
31.05.21
Could be very worthwhile Investment >20% year
Calithera Biosciences Inc.
Start price
Target price
Perf. (%)
€35.80
17.05.21
17.05.21
-
17.05.22
17.05.22
-88.46%
18.05.22
18.05.22
Could be worthwhile Investment >10% per year
MPH Health Care AG
Start price
Target price
Perf. (%)
€26.00
16.05.21
16.05.21
€40.00
16.05.22
16.05.22
-5.77%
29.01.22
29.01.22
Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€74.55
07.05.21
07.05.21
€60.00
07.05.22
07.05.22
-37.42%
08.05.22
08.05.22
Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management